The FPS Course On Prescribing Controlled Substances
Required By Florida HB 21

"The Opioid Epidemic and Florida State Law Prescribing Requirements:
What You Need to Know from HB 21 and More"

The course will:

· Review the history, contributing factors, and the scope of the opioid epidemic.

· Explain the Florida state law requirements for controlled substance prescribing.

· Address the treatment of opioid use disorders alone or in conjunction with another co-morbid mental disorder.

Presenters:
 Scott A. Teitelbaum, MD and William M. Greene, MD

Scott Teitelbaum, MD, is a professor of psychiatry at the University of Florida’s College of Medicine, where he serves as vice chair of the department of psychiatry, chief of the division of addiction medicine, medical director of the UF Health Florida Recovery Center, Pottash Professor in Psychiatry and Neuroscience, fellowship director of UF’s American Board of Addiction Medicine (ABAM) fellowship and a member of the McKnight Brain Institute of the University of Florida. And is currently the President of the Florida Society of Addiction Medicine

A national expert who has been consulted by the White House Office of National Drug Control and the U.S. Drug Enforcement Administration, Dr. Teitelbaum is passionate about reducing stigma and advancing treatment for those suffering from the disease of addiction.

William M. Greene, MD is an Associate Professor in the Department of Psychiatry, Division of Addiction Medicine and Associate Program Director for the Addiction Medicine Fellowship. He currently serves as Attending Physician of the 20 bed drug and alcohol detoxification unit at Shands at Vista. Dr. Greene is board certified by the American Board of Addiction Medicine, the American Board of Psychiatry and Neurology, and also certified by the American Society of Addiction Medicine.

The Florida Psychiatric Society is accredited by the Florida Medical Association to provide
Continuing Medical Education for physicians. The Florida Psychiatric Society designates
this live activity for a maximum of 12.0 AMA PRA Category 1 Credits™. 

Additional FPS CME Course Information

Friday, September 7, 2018

Opening Session: Movie Night - “Loving Vincent” (2.0 CME)
Facilitators: Stefan Pasternack, MD; Caryn Schorr, MD; Elias Sarkis, MD

Saturday, September 8, 2018

The FPS Course On Prescribing Controlled Substances Required By Florida HB-21

The Opioid Epidemic and Florida State Law Prescribing Requirements:
What You Need to Know from HB 21 and More (2.0 CME)
Presenters: Scott A. Teitelbaum, MD; William M. Greene, MD

How to Approach Addiction Treatment in the Era of HB 21 (1.0 CME)
Presenters: Scott A. Teitelbaum, MD; William M. Greene, MDCenter

Specialty Luncheons

Child & Adolescent Luncheon: (1.0 CME)
Exploring Threat Assessment and Management Teams
Presenter: Meggen T. Sixbey, PhD

Forensic Luncheon: (1.0 CME)
Guns, Violence, and Mental Illness
Presenter: Brian K Cooke, MD

Psychotherapy Luncheon: (1.0 CME)
The Art and Science of Psychotherapy for the Next Generation
Presenter: Uma Suryadevara, MD

Presidential Symposium--Physician Wellness and Burnout (1.5 CME)
Presenter: Stefan Pasternack, MD

Psycopharmacological Options in the Treatment of Pharmacologic Treatment of Substance Use Disorders (1.5 CME) 
Presenter: Brian Barnett, MD

Sunday, September 9, 2018

 Cognitive Neuroscience of Universal Mechanisms of Change in Psychotherapy (1.5 CME)
Presenter: Andrew J. Gerber, MD, PhD - Medical Director and CEO, Austen Riggs Center

Why the Physician Recovery Network is a Superior Option to Sanctioning
by the Board Of Medicine (1.5 CME)
Presenter: Alexandria (“Alexis”) Polles, MD

Fall 2018 CME Meeting

WE WISH TO THANK OUR GROWING LIST OF
2018 FALL MEETING EXHIBITORS:

FPS values and appreciates the contributions made by exhibitors who are participating in the FPS 2018 FALL EXPO. In addition to providing information on products, facilities, programs and available services, our exhibitors provide a personal touch.

CORPORATE PARTNERS:

Professional Risk Management Services

Johnson & Johnson

EXHIBITORS:

Alfasigma

American Professional Agency, Inc

Brainsway USA

Genomind, Inc

Hazelden Betty Ford Foundation

Janssen Pharmceuticals, Inc

Lundbeck

McLean Hospital

MHM Services, Inc/Centurian of Florida

Nami

Neurocrine Biosciences, Inc

NeuroStar

Professional Risk Management Services, Inc

Pronto EMR

Takeda

The Vines Hospital

University of Florida Department of Psychiatry

Valeant/Bausch

Vanda Pharma

Wexford Health Sources